Keep up to date with the latest news and articles from Genome Biology and BioMed Central.
William Wells
Correspondence: William Wells wells@biotext.com
Genome Biology 2001, 2:spotlight-20010112-02 doi:10.1186/gb-spotlight-20010112-02
Although metastatic melanomas retain an intact p53, they lose the p53 effector Apaf-1 through deletion and methylation.
